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Objective
To provide preliminary evidence of validity of the JAMAR
in a large sample of JIA patients.
Methods
The JAMAR includes: Juvenile Arthritis Functionality Scale
(JAFS) (0 = normal; 30 = worst), Pediatric Rheumatology
Quality of Life (PRQL) questionnaire (0 = best; 30 =
worst); visual analogue scales (0 = best; 10 = worst) for
parent/patient rating of well-being (WB), pain (P), disease
activity (DA); parent/patient assessment of morning stiff-
ness, disease status, satisfaction about disease outcome.
Results
The JAMAR was completed by 403 parents in 696 visits
between March 2007 and February 2008. All completers
reported that JAMAR was easy to understand and fill.
Completion time was < 10 minutes. Results of quantita-
tive JAMAR assessments are shown in the table 1 together
with assessments made by attending physician.
Conclusion
The JAMAR proved to be feasible and to have good face
and content validity. Parents and physicians revealed fair
concordance in assessing overall disease activity. Around
half and 2/3 of patients, respectively, were judged to be in
remission or in satisfactory state by parents.
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Table 1: Percentage of parents reporting morning stiffness, remission, continued activity, flare, and satisfaction about outcome was 
34.3, 47.9, 29.5, 22.6, and 72.1, respectively.
Parent WB Parent DA Parent P JAFS PRQL MD global No. swollen 
joints
No. tender 
joints
No. restricted 
joints
No. active 
joints
Mean 2.3 2.4 2.1 1.5 3.9 2.3 1.8 2.1 2.1 2.4
Median 1 1 0.5 0 3 0.5 1 0 0 1
Minimum 0 0 0 0 0 0 0 0 0 0
Maximum 10 10 10 26 23 10 35 49 46 49